ETON filings
Corporate insider profile
David Krempa Filing Activity
Latest reported as Chief Business Officer of Eton Pharmaceuticals, Inc. (ETON).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$3,229,920.00
- Latest transaction
- May 27, 2026
Affiliated corporations
Reported company relationships
Transaction history
